Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Novel biomarkers in cardiovascular disease: update 2010.

Hochholzer W, Morrow DA, Giugliano RP.

Am Heart J. 2010 Oct;160(4):583-94. doi: 10.1016/j.ahj.2010.06.010. Review.

PMID:
20934551
2.

Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer.

Mimeault M, Batra SK.

J Cell Physiol. 2010 Sep;224(3):626-35. doi: 10.1002/jcp.22196. Review.

3.

Mismatch repair protein expression is an independent prognostic factor in sporadic colorectal cancer.

Ohrling K, Edler D, Hallström M, Ragnhammar P.

Acta Oncol. 2010 Aug;49(6):797-804. doi: 10.3109/02841861003705786.

PMID:
20307245
4.

Sensitive plasma protein analysis by microparticle-based proximity ligation assays.

Darmanis S, Nong RY, Hammond M, Gu J, Alderborn A, Vänelid J, Siegbahn A, Gustafsdottir S, Ericsson O, Landegren U, Kamali-Moghaddam M.

Mol Cell Proteomics. 2010 Feb;9(2):327-35. doi: 10.1074/mcp.M900248-MCP200. Epub 2009 Nov 27.

5.

Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach.

Xue H, Lü B, Zhang J, Wu M, Huang Q, Wu Q, Sheng H, Wu D, Hu J, Lai M.

J Proteome Res. 2010 Jan;9(1):545-55. doi: 10.1021/pr9008817.

PMID:
19924834
6.

The impact of tissue fixatives on morphology and antibody-based protein profiling in tissues and cells.

Paavilainen L, Edvinsson A, Asplund A, Hober S, Kampf C, Pontén F, Wester K.

J Histochem Cytochem. 2010 Mar;58(3):237-46. doi: 10.1369/jhc.2009.954321. Epub 2009 Nov 9.

7.

Regulation of the histone demethylase JMJD1A by hypoxia-inducible factor 1 alpha enhances hypoxic gene expression and tumor growth.

Krieg AJ, Rankin EB, Chan D, Razorenova O, Fernandez S, Giaccia AJ.

Mol Cell Biol. 2010 Jan;30(1):344-53. doi: 10.1128/MCB.00444-09.

8.

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

Karapetis CS, Khambata-Ford S, Jonker DJ, O'Callaghan CJ, Tu D, Tebbutt NC, Simes RJ, Chalchal H, Shapiro JD, Robitaille S, Price TJ, Shepherd L, Au HJ, Langer C, Moore MJ, Zalcberg JR.

N Engl J Med. 2008 Oct 23;359(17):1757-65. doi: 10.1056/NEJMoa0804385.

9.

MRI for detection of extramural vascular invasion in rectal cancer.

Smith NJ, Shihab O, Arnaout A, Swift RI, Brown G.

AJR Am J Roentgenol. 2008 Nov;191(5):1517-22. doi: 10.2214/AJR.08.1298. Review.

PMID:
18941094
10.

The Human Protein Atlas--a tool for pathology.

Pontén F, Jirström K, Uhlen M.

J Pathol. 2008 Dec;216(4):387-93. doi: 10.1002/path.2440.

PMID:
18853439
11.

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer.

Amado RG, Wolf M, Peeters M, Van Cutsem E, Siena S, Freeman DJ, Juan T, Sikorski R, Suggs S, Radinsky R, Patterson SD, Chang DD.

J Clin Oncol. 2008 Apr 1;26(10):1626-34. doi: 10.1200/JCO.2007.14.7116. Epub 2008 Mar 3.

12.

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

Quasar Collaborative Group, Gray R, Barnwell J, McConkey C, Hills RK, Williams NS, Kerr DJ.

Lancet. 2007 Dec 15;370(9604):2020-9.

PMID:
18083404
13.

Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1.

Johnen H, Lin S, Kuffner T, Brown DA, Tsai VW, Bauskin AR, Wu L, Pankhurst G, Jiang L, Junankar S, Hunter M, Fairlie WD, Lee NJ, Enriquez RF, Baldock PA, Corey E, Apple FS, Murakami MM, Lin EJ, Wang C, During MJ, Sainsbury A, Herzog H, Breit SN.

Nat Med. 2007 Nov;13(11):1333-40. Epub 2007 Nov 4.

PMID:
17982462
14.

Cleavage of growth differentiation factor 15 (GDF15) by membrane type 1-matrix metalloproteinase abrogates GDF15-mediated suppression of tumor cell growth.

Abd El-Aziz SH, Endo Y, Miyamaori H, Takino T, Sato H.

Cancer Sci. 2007 Sep;98(9):1330-5. Epub 2007 Jul 19.

15.

Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials.

Punt CJ, Buyse M, Köhne CH, Hohenberger P, Labianca R, Schmoll HJ, Påhlman L, Sobrero A, Douillard JY.

J Natl Cancer Inst. 2007 Jul 4;99(13):998-1003. Epub 2007 Jun 27. Review.

PMID:
17596575
16.

Measurement of serum levels of macrophage inhibitory cytokine 1 combined with prostate-specific antigen improves prostate cancer diagnosis.

Brown DA, Stephan C, Ward RL, Law M, Hunter M, Bauskin AR, Amin J, Jung K, Diamandis EP, Hampton GM, Russell PJ, Giles GG, Breit SN.

Clin Cancer Res. 2006 Jan 1;12(1):89-96.

17.

Alterations in components of the TGF-beta superfamily signaling pathways in human cancer.

Levy L, Hill CS.

Cytokine Growth Factor Rev. 2006 Feb-Apr;17(1-2):41-58. Epub 2005 Nov 23. Review.

PMID:
16310402
18.

Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer.

Jover R, Zapater P, Castells A, Llor X, Andreu M, Cubiella J, Piñol V, Xicola RM, Bujanda L, Reñé JM, Clofent J, Bessa X, Morillas JD, Nicolás-Pérez D, Payá A, Alenda C; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association.

Gut. 2006 Jun;55(6):848-55. Epub 2005 Nov 18.

19.

A human protein atlas for normal and cancer tissues based on antibody proteomics.

Uhlén M, Björling E, Agaton C, Szigyarto CA, Amini B, Andersen E, Andersson AC, Angelidou P, Asplund A, Asplund C, Berglund L, Bergström K, Brumer H, Cerjan D, Ekström M, Elobeid A, Eriksson C, Fagerberg L, Falk R, Fall J, Forsberg M, Björklund MG, Gumbel K, Halimi A, Hallin I, Hamsten C, Hansson M, Hedhammar M, Hercules G, Kampf C, Larsson K, Lindskog M, Lodewyckx W, Lund J, Lundeberg J, Magnusson K, Malm E, Nilsson P, Odling J, Oksvold P, Olsson I, Oster E, Ottosson J, Paavilainen L, Persson A, Rimini R, Rockberg J, Runeson M, Sivertsson A, Sköllermo A, Steen J, Stenvall M, Sterky F, Strömberg S, Sundberg M, Tegel H, Tourle S, Wahlund E, Waldén A, Wan J, Wernérus H, Westberg J, Wester K, Wrethagen U, Xu LL, Hober S, Pontén F.

Mol Cell Proteomics. 2005 Dec;4(12):1920-32. Epub 2005 Aug 27.

20.

Supplemental Content

Support Center